Literature DB >> 11431034

The importance of specific virus diagnosis and monitoring for antiviral treatment.

A Linde1.   

Abstract

Antiviral treatment, rapid viral diagnosis and point-of-care diagnostics are all relatively new, and their appropriate use not fully appreciated or evaluated. In this article, the need for laboratory diagnosis in relation to antiviral treatment, and practical approaches are discussed, with influenza and herpes simplex virus (HSV) as examples.

Mesh:

Substances:

Year:  2001        PMID: 11431034     DOI: 10.1016/s0166-3542(01)00129-2

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

Review 1.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

2.  Rapid method for detection of influenza a and B virus antigens by use of a two-photon excitation assay technique and dry-chemistry reagents.

Authors:  Janne O Koskinen; Raija Vainionpää; Niko J Meltola; Jori Soukka; Pekka E Hänninen; Aleksi E Soini
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

3.  Synthesis of novel N-acetylneuraminic acid derivatives as substrates for rapid detection of influenza virus neuraminidase.

Authors:  Wei Yang; Xiaoyu Liu; Xiaoxia Peng; Pei Li; Tianxin Wang; Guihua Tai; X James Li; Yifa Zhou
Journal:  Carbohydr Res       Date:  2012-06-21       Impact factor: 2.104

4.  Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.

Authors:  Suma Ghosh; Jane Heffernan
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

5.  Comprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOC® respiratory pathogen test.

Authors:  M Gunell; P Antikainen; N Porjo; K Irjala; J Vakkila; K Hotakainen; S S Kaukoranta; J J Hirvonen; K Saha; R Manninen; B Forsblom; K Rantakokko-Jalava; V Peltola; J O Koskinen; P Huovinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-06       Impact factor: 3.267

6.  Are point-of-care (POC) virological tests what is needed?

Authors:  C R Madeley
Journal:  Clin Microbiol Infect       Date:  2007-07       Impact factor: 8.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.